Search

everythinglearnresearchcommunity

for

Search:↓

GPR40 agonists help hair growth through the protein ANGPTL4.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Certain medications can cause serious side effects, so it's important to report them.

Empagliflozin helps heal diabetic wounds in rats by reducing inflammation and oxidative stress.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Afatinib often causes skin problems that need proactive management.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Dapagliflozin helps protect heart cells under stress by improving mitochondrial function and reducing cell damage.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

GLP-1 receptor agonists may help manage and prevent diabetic foot ulcers.

Gefitinib can cause hair loss without scarring.